Venture
Precision Neuroscience Corp
Latest Form D 2026-09-28- CIK 1858288
- State NY
- Other Health Care
- 5 Form D offerings since 2021-04-28
- Total sold
- $422M
- across 5 offerings
- Rounds
- 5
- Form D offerings since 2021-04-28
- Latest round
- $250M
- 2026-09-28 · 021-599075
- Investors
- 46
- on the latest round
Connected
named in its Form D filingsOfferings · since 2021-04-285 Form D offeringsExemptions506(b)People · Item 3Michael Mager + 8 moreInvestors · dashboard1 inferred investor
Precision Neuroscience CorpCIK 1858288
Round timeline
amount sold · by first filed2026-09-28 · $250M · new
- 2021-04-28$10.5M021-397472
- 2022-12-19$41.2M021-467851
- 2024-04-02$27.5M021-509304
- 2024-10-17$93.1M021-527140
- 2026-09-28$250M021-599075new
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($250M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-599075 | First filed2026-09-28 | Latest2026-09-28 | SoughtIndefinite | Sold$250M | Investors46 | Exemptions506(b) |
| 021-527140 | First filed2024-10-17 | Latest2024-10-17 | Sought$150M | Sold$93.1M | Investors21 | Exemptions506(b) |
| 021-509304 | First filed2024-04-02 | Latest2024-04-02 | Sought$45M | Sold$27.5M | Investors5 | Exemptions506(b) |
| 021-467851 | First filed2022-12-19 | Latest2023-02-01 | Sought$42M | Sold$41.2M | Investors20 | Exemptions506(b) |
| 021-397472 | First filed2021-04-28 | Latest2021-04-28 | Sought$12M | Sold$10.5M | Investors2 | Exemptions506(b) |
Who backs Precision Neuroscience Corp — 1 inferred investor — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2026-09-28
| Name | Relationship | Clarification |
|---|---|---|
| Michael Mager | RelationshipExecutive Officer, Director | ClarificationChief Executive Officer |
| Konstantinos Alataris | RelationshipExecutive Officer, Director | ClarificationPresident |
| Craig Mermel | RelationshipExecutive Officer, Director | ClarificationChief AI and Data Officer |
| Benjamin Rapoport | RelationshipExecutive Officer, Director | ClarificationChief Science Officer |
| Ravi Mehta | RelationshipDirector | Clarification— |
| Howard Morgan | RelationshipDirector | Clarification— |
| Michael Kaswan | RelationshipExecutive Officer | ClarificationChief Financial Officer |
| Michael Goller | RelationshipDirector | Clarification— |
| Stephen Biggar | RelationshipDirector | Clarification— |
Facts
As its latest Form D states them
- Industry
- Other Health Care
- State
- New York (NY)
- Exemptions
- Rule 506(b)
- First filed
- 2021-04-28
- Latest filing
- 2026-09-28
Who backs Precision Neuroscience Corp
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗